A former physician with practices in New Jersey, New York, and Florida has pleaded guilty to criminal violations of HIPAA for disclosing patients’ protected health information to a sales representative of a pharmaceutical firm, according to the U.S. Attorney’s Office of the District of New Jersey.
The Frank Alario, 65, of Delray Beach, Florida, pleaded guilty to disclosing patient information to sales rep, Keith Ritson, who promoted compound prescription medications and other medications to the patients. Compound prescription medications are medications mixed specifically for individual patients when standard FDA-approved medications are determined to not be appropriate, due to an allergy for example. Compound prescription medications are not approved by the FDA but can be legally prescribed by physicians.
The HIPAA Privacy Rule permits disclosures of patients’ protected health information for the purposes of treatment, payment, or healthcare operations; however, other disclosures are only permitted if consent to share information is provided by each patient. Ritson was an outside pharmaceutical representative who was not associated with Alario’s practices, and as such Ritson was not permitted to access the protected health information of Alario’s patients. Permission to disclose the information was not provided by patients.
Alario allowed Ritson to have significant access to his office, patients’ medical files, and other patient information, both inside and outside normal business hours. Ritson was given access to areas of Alario’s office that were restricted to staff members, such as areas with patient files and computers. In addition to allowing access to these areas, Ritson was allowed to look up patient information in files and on computers to identify patients who had insurance coverage that would pay for the compound medications. Ritson would then mark the files of patients whose insurance would pay for the medications so Alario would know which patients to prescribe the medications to.
In some cases, Ritson was allowed to be present during appointments. Alario gave patients the impression that Ritson was a member of staff or was affiliated with the medical practice and during those appointments sensitive health information would be directly disclosed to Ritson. The information obtained was then used to fill out prescription forms for medications, which would then be authorized by Alario, with Ritson receiving a commission on the prescribed prescriptions.
Alario and Ritson were both charged in an indictment for conspiring to violate HIPAA. Ritson’s charges are still pending, with his trial scheduled for November 7, 2022. Alario pleaded guilty and sentencing is scheduled for February 7, 2023. Alario faces a maximum of one year in jail and a $50,000 fine.
The post Doctor Who Provided PHI to Pharma Sales Rep Pleads Guilty to Criminal Violations of HIPAA appeared first on HIPAA Journal.